NANOEMULSIONS AS PARENTERAL DRUG DELIVERY SYSTEMS

被引：66

作者：

Bruxel, Fernanda ^{[1
]}

Laux, Manoela ^{[1
]}

Wild, Luisa Bartmann ^{[1
]}

Fraga, Michelle ^{[1
]}

Koester, Leticia S. ^{[1
]}

Teixeira, Helder F. ^{[1
]}

机构：

[1] Univ Fed Rio Grande do Sul, Fac Farm, BR-90610000 Porto Alegre, RS, Brazil

来源：

QUIMICA NOVA | 2012年 / 35卷 / 09期

关键词：

emulsion; parenteral; drug; OIL-IN-WATER; SUBMICRON LIPID EMULSION; VITRO RELEASE; PHYSICOCHEMICAL PROPERTIES; INTRAVENOUS EMULSION; PROSTAGLANDIN E(1); O/W-EMULSION; INJECTABLE EMULSIONS; TISSUE DISTRIBUTION; RICH NANOEMULSION;

D O I：

10.1590/S0100-40422012000900023

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

NANOEMULSIONS AS PARENTERAL DRUG DELIVERY SYSTEMS. Lipid nanoemulsions have recently been proposed as parenteral delivery systems for poorly-soluble drugs. These systems consist of nanoscale oil/water dispersions stabilized by an appropriate surfactant system in which the drug is incorporated into the oil core and/or adsorbed at the interface. This article reviews technological aspects of such nanosystems, including their composition, preparation methods, and physicochemical properties. From this review, it was possible to identify five groups of nanoemulsions based on their composition. Biopharmaceutical aspects of formulations containing some commercially available drugs (diazepam, propofol, dexamethasone, etomidate, flurbiprofen and prostaglandin E1) were then discussed.

引用

页码：1827 / 1840

页数：14

共 157 条

[1] Intravenous itraconazole emulsions produced by SolEmuls technology [J].

Akkar, A ;

Müller, RH .

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2003, 56 (01) :29-36

[2] Formulation of intravenous Carbamazepine emulsions by SolEmuls® technology [J].

Akkar, A ;

Müller, RH .

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2003, 55 (03) :305-312

[3]

Akkar A., 2004, AAPS PHARMSCITECH, V5, P1

[4]

Almeida ME, 2008, LAT AM J PHARM, V27, P780

[5] Nano-emulsions and Micro-emulsions: Clarifications of the Critical Differences [J].

Anton, Nicolas ;

Vandamme, Thierry F. .

PHARMACEUTICAL RESEARCH, 2011, 28 (05) :978-985

[6]

Araujo F. A., 2010, EUR J PHARM SCI

[7] Propofol - The challenges of formulation [J].

Baker, MT ;

Naguib, M .

ANESTHESIOLOGY, 2005, 103 (04) :860-876

[8] Randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of AS-013, a prostaglandin E-1 prodrug, in patients with intermittent claudication [J].

Belch, JJF ;

Bell, PRF ;

Creissen, D ;

Dormandy, JA ;

Kester, RC ;

McCollum, RD ;

Mizushima, Y ;

Ruckley, CV ;

Scurr, JH ;

Wolfe, JHN .

CIRCULATION, 1997, 95 (09) :2298-2302

[9] SUBMICRON EMULSIONS AS COLLOIDAL DRUG CARRIERS FOR INTRAVENOUS ADMINISTRATION - COMPREHENSIVE PHYSICOCHEMICAL CHARACTERIZATION [J].

BENITA, S ;

LEVY, MY .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1993, 82 (11) :1069-1079

[10] Improvement of in vitro efficacy of a novel schistosomicidal drug by incorporation into nanoemulsion's [J].

Caldeira de Araújo, Savia ;

Alves de Mattos, Ana Carolina ;

Teixeira, Helder Ferreira ;

Zech Coelho, Paulo Marcos ;

Nelson, David Lee ;

de Oliveira, Monica Cristina .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 337 (1-2) :307-315

← 1 2 3 4 5 6 7 8 9 10 →